One of the other candidates identified in this screen, TACC1, has been shown to enhance mammary tumor formation induced by heterozygous PTEN loss in vivo and was shown to mediate cell survival following PI3K pathway inhibition induced by PTEN over expression (Cully et al., 2005). This evidence concerns the gene PTEN and breast cancer.